Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

M Agrawal, S Saraf, S Saraf, SG Antimisiaris… - Journal of controlled …, 2018 - Elsevier
Abstract According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is
the 6th primary cause of death in the USA, which affects nearly 5.5 million people. In the …

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.

M Agrawal, S Saraf, SG Antimisiaris… - Journal of Controlled …, 2018 - europepmc.org
According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is the 6th
primary cause of death in the USA, which affects nearly 5.5 million people. In the year 2017 …

[引用][C] Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

M Agrawal, S Saraf, S Saraf, SG Antimisiaris… - Journal of Controlled …, 2018 - cir.nii.ac.jp
Nose-to-brain drug delivery: An update on clinical challenges and progress towards
approval of anti-Alzheimer drugs | CiNii Research CiNii 国立情報学研究所 学術情報 …

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

M Agrawal, A Alexander, S Saraf… - Journal of Controlled …, 2018 - elibrary.ru
The author wants to acknowledge Rungta College of Pharmaceutical Sciences and
Research, Bhilai, Chhattisgarh, for all the essential facilities to complete this work. We are …

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

M Agrawal, S Saraf, S Saraf… - … : official journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is the 6th
primary cause of death in the USA, which affects nearly 5.5 million people. In the year 2017 …

[引用][C] Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

M Agrawal, S Saraf, S Saraf, SG Antimisiaris… - 2018